Related Experiment Video
Updated: Apr 13, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Statins and cognitive side effects: what cardiologists need to know
Carlos Rojas-Fernandez1, Zain Hudani2, Vera Bittner3
1Schlegel-UW Research Institute for Ageing & School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada; School of Public Health and Health Systems, Faculty of Applied Health Sciences, University of Waterloo, Waterloo, Ontario, Canada; Michael G. DeGroote School of Medicine, Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.
Statins are crucial for preventing cardiovascular disease and have a good safety profile. While some reports link statins to cognitive issues, current evidence suggests cognitive side effects should not deter their use for most patients.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Statins are primary and secondary prevention agents for atherosclerotic cardiovascular disease.
- They effectively reduce cardiovascular events and mortality with a favorable safety record.
- Emerging case reports suggest a potential link between statin use and cognitive adverse effects.
Purpose of the Study:
- To review current literature on the association between statins and cognitive function.
- To provide clinical recommendations regarding cognitive concerns in patients prescribed statins.
Main Methods:
- Literature review of recent studies investigating statins and cognition.
- Synthesis of evidence regarding reported cognitive effects.
- Formulation of clinical guidance based on existing data.
Main Results:
- The overall evidence does not indicate that cognitive effects should prevent statin initiation for indicated patients.
- Existing literature is primarily based on case reports, necessitating further investigation.
- Systematic cognitive assessment is recommended for future clinical trials.
Conclusions:
- For the majority of patients indicated for statin therapy, potential cognitive effects should not influence prescribing decisions.
- Clinicians should remain aware of reported cognitive associations but not unduly தடுக்க statin use.
- Future research, including trials of statins and other lipid-lowering agents, must incorporate standardized cognitive assessments.
More Related Videos
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Alzheimer's Disease: Treatment
Anxiolytic Drugs: Benzodiazepines and Buspirone
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...

